Bothell-based BioLife Solutions’ CryoStor® integrated in Kolon group’s cell-mediated gene therapy for Osteoarthritis

Bothell-based BioLife Solutions, Inc. today announced that its clinical grade CryoStor freeze media has been incorporated into the manufacturing process for Invossa, a cell-mediated gene therapy for knee osteoarthritis to be marketed by Kolon Life Science.

  • Wednesday, August 24, 2016 4:30pm
  • Business

Bothell-based BioLife Solutions, Inc. today announced that its clinical grade CryoStor freeze media has been incorporated into the manufacturing process for Invossa, a cell-mediated gene therapy for knee osteoarthritis to be marketed by Kolon Life Science.

The Kolon Group subsidiary filed as of July 8 a biologics license application (BLA) for Invossa with the Korean Ministry of Food and Drug Safety. According to Kolon, Invossa is the world’s first cell-mediated gene therapy for osteoarthritis, a degenerative joint disease affecting more than 150 million people. The product was developed by US-based TissueGene, Inc. as “TissueGene-C” and is administered via intra-articular injection without the need for anesthesia or surgical intervention. The therapy has demonstrated effectiveness in providing pain and symptomatic relief as well as in delaying the disease’s structural progression.

“Kolon’s BLA submission seeking approval to market Invossa in Korea is encouraging news for millions of patients suffering from osteoarthritis,” said BioLife President and CEO Mike Rice. “We are very pleased that TissueGene and Kolon have selected CryoStor as the best in class biopreservation media for commercializing Invossa. CryoStor and HypoThermosol®, our cell and tissue storage and shipping media, are now incorporated into more than 220 pre-clinical validations and clinical trials of cell-based therapies, targeting blood cancers, solid tumors, vision loss, heart disease, stroke, and movement disorders such as osteoarthritis. We look forward to progress by Kolon and other customers in gaining regulatory approvals to commence commercial manufacturing of these life-changing and life-saving cell therapies.”

More in Business

Decreased inventory for buyers in local real estate market

During the season, many sellers don’t want to get their holidays interrupted by the selling process.

Business alliance serves women of African diaspora in King County

Nourah Yonous launched the African Women Business Alliance in 2017 to find ways to lift women up.

Bothell and Kenmore real estate market transitions into fall

There may be less competition than last year but well-priced homes in great locations can still garner more than one offer.

BECU to expand Northshore presence with new financial center in Bothell

Local credit union to open new Neighborhood Financial Center next spring

Business networking open house coming to Kenmore Oct. 3

The event is sponsored by the city and the Bothell-Kenmore Chamber of Commerce.

Change to U.S.-backed condo loans comes as summer market wraps up

A monthly real estate snap shot by John L. Scott Real Estate.

First AG lawsuit against company no-poach clause ends with $150K payment

Jersey Mike’s had the contract provisions in place until April 2018.

Dr. Khalid Ahmed (left) and Dr. Elina Durchman are excited to start their new intensive program in Sept. Stephanie Quiroz/staff photo
Bothell’s Center of Body Mind Intuition to start intensive outpatient program

Center’s intensive outpatient program to start end of September.

Courtesy photo 
                                Mercer Island financial adviser Bob Toomey recently summited Mount Shasta in California.
Financial success and mountaineering

The steps to achieving financial success mirror mountain climbing.

Real estate market holds steady as summer continues

Suburbs are on the rise, as many millennials may be priced out of city cores.

The new Bothell Friday Market will run from 3-8 p.m., every Friday through Sept. 27. Stephanie Quiroz/staff photo
New Bothell Friday Market opens

Bothell Friday Market will run every Friday through Sept. 27